2018
DOI: 10.1016/j.ejmech.2018.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Anti-leishmanial click modifiable thiosemicarbazones: Design, synthesis, biological evaluation and in silico studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(25 citation statements)
references
References 44 publications
2
23
0
Order By: Relevance
“…119 To address this issue, novel hybrid compounds bearing 1,2,3triazole and thiosemicarbazone moieties were identified by Temraz et al [1 2 0] and evaluated for anti-leishmanial potential. 120 Notably, hybrid 90 (Fig. 11) demonstrated nanomolar activity against Leishmania major promastigotes (IC 50 = 140.3 nM), while against axenic amastigotes, the IC 50 value was 1 µM, indicating an 8-fold higher activity than that of miltefosine.…”
Section: Anti-leishmanial Activitymentioning
confidence: 99%
“…119 To address this issue, novel hybrid compounds bearing 1,2,3triazole and thiosemicarbazone moieties were identified by Temraz et al [1 2 0] and evaluated for anti-leishmanial potential. 120 Notably, hybrid 90 (Fig. 11) demonstrated nanomolar activity against Leishmania major promastigotes (IC 50 = 140.3 nM), while against axenic amastigotes, the IC 50 value was 1 µM, indicating an 8-fold higher activity than that of miltefosine.…”
Section: Anti-leishmanial Activitymentioning
confidence: 99%
“…This scoring value is idealized to represent the thermodynamic values of the interaction between the acceptor and the ligand. In practical research, the molecular docking score is widely used [ 46 ]. Fong P. et al used molecular docking scores to evaluate the possibility of cordycepin and its derivatives as therapeutic agents for endometrial cancer [ 28 ].…”
Section: Virtual Screening Technologymentioning
confidence: 99%
“…In a recent study, Temraz et al (2018) reported the design of 1,2,3-triazole and thiosemicarbazone hybrids as novel antileishmanial compounds and the calculation of their ADMET profile. Out of the 17 evaluated molecules, most of them exhibited biological activity that is comparable or superior to that of the reference drug miltefosine.…”
Section: Structure- and Ligand-based Strategies In Leishmaniasis Drugmentioning
confidence: 99%